Sökning: "prostate specificity"
Visar resultat 1 - 5 av 31 avhandlingar innehållade orden prostate specificity.
1. TARP Promoter-Based Prostate Cancer Gene Therapy : From Development to Application
Sammanfattning : Prostate cancer is one leading cause of cancer-related death among men in Western countries. The standard therapies for localized prostate cancer include radical prostatectomy and radiation therapy. Such measures are relatively effective in the short term, but many patients ultimately relapse. LÄS MER
2. Prostate cancer sensor : combining Raman spectroscopy and tactile resonance technology
Sammanfattning : Prostate cancer (PCa) is the most common cancer type among men in Sweden. The most prevalent curative treatment for PCa is radical prostatectomy (RP), i.e., complete surgical removal of the prostate. LÄS MER
3. Adoptive T Cell Therapy of Viral Infection and Cancer : Ex vivo Expansion of Cytomegalovirus- and Prostate Antigen-specific T Cells
Sammanfattning : The main focus of my thesis has been to develop protocols for generating antigen-specific cytotoxic T lymphocytes (CTLs) and T helper cells (TH) for adoptive transfer to treat cytomegalovirus (CMV) disease and prostate cancer. CMV viremia is a severe complication in immunocompromised stem cell transplanted patients. LÄS MER
4. PET and MRI of Prostate Cancer
Sammanfattning : Prostate cancer (PCa) is the most common non-skin malignancy of men in developed countries. In spite of treatment with curative intent up to 30-40% of patients have disease recurrence after treatment, resulting from any combination of lymphatic, hematogenous, or contiguous local spread. LÄS MER
5. Theranostic Targeting of GRPR and PSMA in Prostate Cancer
Sammanfattning : This thesis is based on five original articles that investigated the theranostics of prostate cancer by gastrin-releasing peptide receptor (GRPR) and prostate-specific membrane antigen (PSMA) targeting. GRPR and PSMA are two extensively evaluated prostate cancer cell markers due to their overexpression in the majority of prostate cancer samples. LÄS MER